Compare LOPE & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOPE | MIR |
|---|---|---|
| Founded | 1949 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Other Consumer Services | Industrial Machinery/Components |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.6B |
| IPO Year | 2008 | N/A |
| Metric | LOPE | MIR |
|---|---|---|
| Price | $159.75 | $18.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $220.00 | $27.25 |
| AVG Volume (30 Days) | 237.8K | ★ 3.6M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.80 | N/A |
| Revenue | ★ $511,257,000.00 | N/A |
| Revenue This Year | $8.67 | $23.95 |
| Revenue Next Year | $6.66 | $7.32 |
| P/E Ratio | ★ $57.45 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $149.37 | $16.84 |
| 52 Week High | $223.04 | $30.28 |
| Indicator | LOPE | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 39.97 | 40.45 |
| Support Level | $151.84 | $16.98 |
| Resistance Level | $172.89 | $20.70 |
| Average True Range (ATR) | 5.56 | 0.88 |
| MACD | -0.69 | -0.14 |
| Stochastic Oscillator | 17.67 | 17.03 |
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.